SOSV: Venture Capital in the Health Diagnostics Sector

31/01/2020
Diego Gutiérrez
SOSV: Venture Capital in the Health Diagnostics Sector

SOSV is one of the world's leading Venture Capital into the Health Diagnosticswith a total of 17 investments since 2013.

Its objective is clear: to acquire shareholding in the sector.

This is clear from the Baker Tilly study.

Baker Tilly has produced a study covering 1733 companies from around the world, labelled within the category "...".Diagnostics".

In particular, in the category "Health Diagnostics1043 "The number of roundsand has funds valued at $12.78B.

It is worth noting that due to the characteristics of the sector, Venture Capital firms are common in the sector.

TOP COMPANIES IN HEALTH DIAGNOSTICS

ROCHE

It is a Swiss company, pioneer in providing specific treatments to patients.

Roche provides automated instruments, software, consumables and informatics solutions for in vitro diagnostics and research.

BIOMERIEUX

Biomerieux is a French company, which designs, develops, manufactures and markets in vitro diagnostic systems for clinical and industrial applications..

These include the diagnosis of infectious diseases, cardiovascular diseases and specific cancers.

QUIDEL

Quidel is an American company dedicated to the development, manufacturing and commercialisation of diagnostic solutions for POC (Ponit of Care).

In particular, for infectious diseases and women's reproductive health.

In the following, we will analyse SOSVone of the leading investment firms in Venture Capital in the sector Health Diagnostics.

SOSV

It is a investment firm of Venture Capital which provides multi-stage funding, especially early-stage funding to start-up companies with rounds seed.

It helps develop and scale great ideas from new founders, through financial and intellectual capital.

To date, SOSV has financed more than 900 start-ups.

IDEOLOGY AND VALUES

For SOSV, building a better future means empowering the next generation of entrepreneurs.

Only in this way will they be able to solve the major challenges of today's world.

Notably, almost half of the firm's portfolio is aligned with the United Nations Sustainable Development Goals.

In addition, SOSV is proud to be one of the leading investors in companies founded by women.

SOSV: Venture Capital in the Health Diagnostics SectorSOSV: Venture Capital in the Health Diagnostics SectorSOSV: Venture Capital in the Health Diagnostics Sector

INVESTMENTS MADE IN THE SECTOR

As can be seen from the data shown above, from 2013 to the recently ended 2019, SOSV has made a total of 25 investments, thanks to which has acquired numerous actions by companies in the Health Diagnostics.

2018 was the most productive year, with 8.

As a good firm of Venture CapitalOf those, 25 investments, 17 were in the seedwhile the remaining 8 took place in Late Stage.

The US is the country that has benefited most from them.

Lastest news

Webinar | Cómo maximizar el valor de tu empresa antes de vender

INFORMACIÓN IMPORTANTE: La inscripción y participación en los webinars es totalmente anónima para terceros Cómo maximizar el valor de tu empresa antes de vender Maximizar el valor de tu empresa antes de vender es, casi siempre, el trabajo más rentable que puede hacer...

The State of technology M&A in Spain | May 2026 Analysis

El M&A tecnológico en España registró en mayo de 2026 36 operaciones identificadas con un importe agregado conocido de aproximadamente 720,7 millones de euros. La cifra es una referencia mínima: 13 transacciones no hicieron público su importe. El mes combinó...

Notable technology M&A deals in Spain | Analysis: April 2026

The market for the sale and acquisition of technology companies in Spain once again saw particularly brisk activity in April 2026. The month saw significant deals in vertical software, cybersecurity, cloud computing, payments, artificial intelligence, telecommunications...

What does Constellation Software teach us about real value in tech M&A?

An analysis by Diego Gutiérrez Zarza, Partner at Baker Tilly Tech M&A For years, growth was enough to build value in a technology company. That is no longer the case. The market continues to pay a premium for good software companies, but it no longer rewards growth for its own sake...

Do you want to sell or buy a company?

We are experts in M&A transactions in the technology sector.

Subscribe to our newsletter

    On which topic would you like to receive information?

    Request for information

    If you want to buy or sell a company, or need more information about our services, do not hesitate to contact us through the form.

    Or if you prefer, call us at:

    +34 946 42 41 42